Wells Fargo Remains a Hold on Clorox (CLX)
In a report released on February 20, Christopher Carey from Wells Fargo maintained a Hold rating on Clorox, with a price target of $125.00. The company’s shares closed yesterday at $123.60.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Carey is a 4-star analyst with an average return of 2.7% and a 52.44% success rate. Carey covers the Consumer Defensive sector, focusing on stocks such as Church & Dwight, Conagra Brands, and Clorox.
The word on The Street in general, suggests a Hold analyst consensus rating for Clorox with a $120.14 average price target, implying a -2.80% downside from current levels. In a report released on February 22, Morgan Stanley also maintained a Hold rating on the stock with a $136.00 price target.
Based on Clorox’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.67 billion and a net profit of $157 million. In comparison, last year the company earned a revenue of $1.69 billion and had a net profit of $193 million
Read More on CLX:
Disclaimer & DisclosureReport an Issue
- Clorox: Margin Recovery Achieved but Ambitious Growth Targets Keep Rating at Hold
- Clorox price target raised to $124 from $112 at BofA
- Clorox price target raised to $125 from $115 at Wells Fargo
- Clorox price target raised to $117 from $115 at Rothschild & Co Redburn
- Clorox Earnings Call: Innovation, ERP Wins, Margin Hopes
